Do analysts rate BDMD or INGN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better earnings and valuation, BDMD or INGN?

Baird Medical Investment has higher earnings, but lower revenue than Inogen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.22 N/A N/A N/A Inogen $348.67M 0.47 -$22.75M -$0.90 N/A

Does the media favor BDMD or INGN?

In the previous week, Inogen had 8 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for Inogen and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Inogen's score of 0.28 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inogen 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BDMD or APYX?

Apyx Medical has a consensus target price of $6.60, suggesting a potential upside of 90.75%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Apyx Medical 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.71

Which has better earnings & valuation, BDMD or APYX?

Baird Medical Investment has higher earnings, but lower revenue than Apyx Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.22 N/A N/A N/A Apyx Medical $52.84M 2.76 -$11.21M -$0.20 N/A

Does the media prefer BDMD or APYX?

In the previous week, Apyx Medical had 19 more articles in the media than Baird Medical Investment. MarketBeat recorded 20 mentions for Apyx Medical and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Apyx Medical's score of 0.58 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts recommend BDMD or STIM?

Neuronetics has a consensus price target of $4.00, suggesting a potential upside of 84.33%. Given Neuronetics' stronger consensus rating and higher probable upside, analysts clearly believe Neuronetics is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Neuronetics 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable earnings & valuation, BDMD or STIM?

Baird Medical Investment has higher earnings, but lower revenue than Neuronetics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.22 N/A N/A N/A Neuronetics $149.16M 1.01 -$39M -$0.54 N/A

Does the media prefer BDMD or STIM?

In the previous week, Neuronetics had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for Neuronetics and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Neuronetics' score of 0.05 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neuronetics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BDMD or OWLT?

Owlet has a consensus target price of $15.00, indicating a potential upside of 175.74%. Given Owlet's stronger consensus rating and higher probable upside, analysts clearly believe Owlet is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Owlet 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better earnings & valuation, BDMD or OWLT?

Baird Medical Investment has higher earnings, but lower revenue than Owlet. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.22 N/A N/A N/A Owlet $105.70M 1.50 -$39.68M -$3.07 N/A

Is BDMD or OWLT more profitable?

Baird Medical Investment has a net margin of 0.00% compared to Owlet's net margin of -42.54%. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A Owlet -42.54% N/A -18.02%

Does the media prefer BDMD or OWLT?

In the previous week, Baird Medical Investment and Baird Medical Investment both had 1 articles in the media. Baird Medical Investment's average media sentiment score of 0.99 beat Owlet's score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Owlet 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CVRX or BDMD?

CVRx currently has a consensus target price of $6.90, indicating a potential upside of 191.14%. Given CVRx's stronger consensus rating and higher probable upside, equities research analysts clearly believe CVRx is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.33 Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, CVRX or BDMD?

Baird Medical Investment has lower revenue, but higher earnings than CVRx. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 1.11 -$53.31M -$1.98 N/A Baird Medical Investment $22.54M 2.22 N/A N/A N/A

Does the media refer more to CVRX or BDMD?

In the previous week, CVRx had 21 more articles in the media than Baird Medical Investment. MarketBeat recorded 22 mentions for CVRx and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat CVRx's score of -0.46 indicating that Baird Medical Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Neutral Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Baird Medical Investment (BDMD) Competitors

$1.22 0.00 (0.00%)

Closing price 08/10/2026 04:00 PM Eastern

Extended Trading

$1.25 +0.03 (+2.05%)

As of 05:29 AM Eastern

Compare

BDMD vs. INGN, APYX, STIM, OWLT, and CVRX

Should you buy Baird Medical Investment stock or one of its competitors? Baird Medical Investment's main competitors and comparable companies include Inogen (INGN), Apyx Medical (APYX), Neuronetics (STIM), Owlet (OWLT), and CVRx (CVRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Baird Medical Investment compare to Inogen?

Baird Medical Investment (NASDAQ:BDMD) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

In the previous week, Inogen had 8 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for Inogen and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Inogen's score of 0.28 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inogen	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Baird Medical Investment has a net margin of 0.00% compared to Inogen's net margin of -6.94%. Baird Medical Investment's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Inogen	-6.94%	-13.17%	-8.36%

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Comparatively, 2.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Baird Medical Investment has a beta of -1.16, meaning that its share price is 216% less volatile than the broader market. Comparatively, Inogen has a beta of 1.55, meaning that its share price is 55% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Baird Medical Investment has higher earnings, but lower revenue than Inogen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A
Inogen	$348.67M	0.47	-$22.75M	-$0.90	N/A

Summary

Baird Medical Investment and Inogen tied by winning 6 of the 12 factors compared between the two stocks.

How does Baird Medical Investment compare to Apyx Medical?

Baird Medical Investment (NASDAQ:BDMD) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 15.9% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Baird Medical Investment has a net margin of 0.00% compared to Apyx Medical's net margin of -14.78%. Baird Medical Investment's return on equity of 0.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Apyx Medical	-14.78%	-76.60%	-13.91%

Baird Medical Investment has higher earnings, but lower revenue than Apyx Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A
Apyx Medical	$52.84M	2.76	-$11.21M	-$0.20	N/A

Baird Medical Investment has a beta of -1.16, indicating that its stock price is 216% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market.

In the previous week, Apyx Medical had 19 more articles in the media than Baird Medical Investment. MarketBeat recorded 20 mentions for Apyx Medical and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Apyx Medical's score of 0.58 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Apyx Medical has a consensus target price of $6.60, suggesting a potential upside of 90.75%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

Summary

Apyx Medical beats Baird Medical Investment on 9 of the 14 factors compared between the two stocks.

How does Baird Medical Investment compare to Neuronetics?

Baird Medical Investment (NASDAQ:BDMD) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 8.4% of Neuronetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Baird Medical Investment has higher earnings, but lower revenue than Neuronetics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A
Neuronetics	$149.16M	1.01	-$39M	-$0.54	N/A

Neuronetics has a consensus price target of $4.00, suggesting a potential upside of 84.33%. Given Neuronetics' stronger consensus rating and higher probable upside, analysts clearly believe Neuronetics is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Neuronetics had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for Neuronetics and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat Neuronetics' score of 0.05 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neuronetics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Baird Medical Investment has a beta of -1.16, indicating that its stock price is 216% less volatile than the broader market. Comparatively, Neuronetics has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to Neuronetics' net margin of -24.48%. Baird Medical Investment's return on equity of 0.00% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Neuronetics	-24.48%	-139.83%	-27.13%

Summary

Neuronetics beats Baird Medical Investment on 7 of the 13 factors compared between the two stocks.

How does Baird Medical Investment compare to Owlet?

Baird Medical Investment (NASDAQ:BDMD) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

Baird Medical Investment has a beta of -1.16, indicating that its share price is 216% less volatile than the broader market. Comparatively, Owlet has a beta of 1.85, indicating that its share price is 85% more volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to Owlet's net margin of -42.54%.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Owlet	-42.54%	N/A	-18.02%

Baird Medical Investment has higher earnings, but lower revenue than Owlet.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A
Owlet	$105.70M	1.50	-$39.68M	-$3.07	N/A

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Owlet has a consensus target price of $15.00, indicating a potential upside of 175.74%. Given Owlet's stronger consensus rating and higher probable upside, analysts clearly believe Owlet is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Baird Medical Investment and Baird Medical Investment both had 1 articles in the media. Baird Medical Investment's average media sentiment score of 0.99 beat Owlet's score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Owlet	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Owlet beats Baird Medical Investment on 6 of the 11 factors compared between the two stocks.

How does Baird Medical Investment compare to CVRx?

CVRx (NASDAQ:CVRX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

CVRx has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.16, meaning that its stock price is 216% less volatile than the broader market.

CVRx currently has a consensus target price of $6.90, indicating a potential upside of 191.14%. Given CVRx's stronger consensus rating and higher probable upside, equities research analysts clearly believe CVRx is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.33
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, CVRx had 21 more articles in the media than Baird Medical Investment. MarketBeat recorded 22 mentions for CVRx and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.99 beat CVRx's score of -0.46 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	1 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	4 Negative mention(s)	2 Very Negative mention(s)	Neutral
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baird Medical Investment has lower revenue, but higher earnings than CVRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.11	-$53.31M	-$1.98	N/A
Baird Medical Investment	$22.54M	2.22	N/A	N/A	N/A

75.3% of CVRx shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Baird Medical Investment has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Baird Medical Investment's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Baird Medical Investment	N/A	N/A	N/A

Summary

CVRx beats Baird Medical Investment on 8 of the 14 factors compared between the two stocks.

Get Baird Medical Investment News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BDMD vs. The Competition

Export

Metric	Baird Medical Investment	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$49.99M	$5.82B	$7.01B	$12.98B
Dividend Yield	N/A	1.78%	2.58%	10.06%
P/E Ratio	N/A	24.72	269.18	24.72
Price / Sales	2.22	39.74	585.57	96.21
Price / Cash	N/A	33.55	28.89	37.42
Price / Book	N/A	6.21	11.40	6.42
Net Income	N/A	$147.87M	$3.45B	$347.03M
7 Day Performance	10.91%	1.12%	1.96%	0.71%
1 Month Performance	7.96%	1.69%	-0.55%	-0.87%
1 Year Performance	-43.52%	5.41%	75.51%	21.94%

Baird Medical Investment Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BDMD Baird Medical Investment	1.4063 of 5 stars	$1.22 flat	N/A	-45.3%	$49.99M	$22.54M	N/A	N/A	News Coverage
INGN Inogen	1.2645 of 5 stars	$6.52 -5.9%	N/A	-7.1%	$176.56M	$348.67M	N/A	1,030	Earnings Report
APYX Apyx Medical	3.0617 of 5 stars	$4.14 -3.2%	$6.60 +59.4%	+58.7%	$173.55M	$52.84M	N/A	270	Earnings Report Gap Down
STIM Neuronetics	3.2304 of 5 stars	$2.42 +5.0%	$4.00 +65.6%	-47.5%	$165.28M	$149.16M	N/A	180
OWLT Owlet	2.3058 of 5 stars	$5.60 +4.9%	$15.00 +167.7%	-41.8%	$162.74M	$105.70M	N/A	106	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BDMD) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baird Medical Investment (BDMD) Competitors

BDMD vs. INGN, APYX, STIM, OWLT, and CVRX

How does Baird Medical Investment compare to Inogen?

Summary

How does Baird Medical Investment compare to Apyx Medical?

Summary

How does Baird Medical Investment compare to Neuronetics?

Summary

How does Baird Medical Investment compare to Owlet?

Summary

How does Baird Medical Investment compare to CVRx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baird Medical Investment (BDMD) Competitors

BDMD vs. INGN, APYX, STIM, OWLT, and CVRX

How does Baird Medical Investment compare to Inogen?

Does the media favor BDMD or INGN?

Is BDMD or INGN more profitable?

Do insiders & institutionals have more ownership in BDMD or INGN?

Which has more risk & volatility, BDMD or INGN?

Do analysts rate BDMD or INGN?

Which has better earnings and valuation, BDMD or INGN?

Summary

How does Baird Medical Investment compare to Apyx Medical?

Do insiders and institutionals have more ownership in BDMD or APYX?

Is BDMD or APYX more profitable?

Which has better earnings & valuation, BDMD or APYX?

Which has more risk & volatility, BDMD or APYX?

Does the media prefer BDMD or APYX?

Do analysts prefer BDMD or APYX?

Summary

How does Baird Medical Investment compare to Neuronetics?

Do insiders and institutionals hold more shares of BDMD or STIM?

Which has preferable earnings & valuation, BDMD or STIM?

Do analysts recommend BDMD or STIM?

Does the media prefer BDMD or STIM?

Which has more volatility & risk, BDMD or STIM?

Is BDMD or STIM more profitable?

Summary

How does Baird Medical Investment compare to Owlet?

Which has more volatility and risk, BDMD or OWLT?

Is BDMD or OWLT more profitable?

Which has better earnings & valuation, BDMD or OWLT?

Do insiders & institutionals believe in BDMD or OWLT?

Do analysts prefer BDMD or OWLT?

Does the media prefer BDMD or OWLT?

Summary

How does Baird Medical Investment compare to CVRx?

Which has more risk & volatility, CVRX or BDMD?

Do analysts prefer CVRX or BDMD?

Does the media refer more to CVRX or BDMD?

Which has stronger earnings & valuation, CVRX or BDMD?

Do insiders and institutionals believe in CVRX or BDMD?

Is CVRX or BDMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools